Ascend Capital’s Bausch Health BHC Stock Holding History

Ascend Capital’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-80,000	Closed	-$8.13M	–	106
2015 Q4	$8.13M	Sell	80,000 -15,865	-17%	-$1.78M	0.29%	88
2015 Q3	$17.1M	Sell	95,865 -75,295	-44%	-$17.6M	0.67%	49
2015 Q2	$38M	Buy	171,160 +25,131	+17%	+$5.57M	1.25%	24
2015 Q1	$29M	Sell	146,029 -25,302	-15%	-$4.49M	1%	33
2014 Q4	$24.5M	Sell	171,331 -76,779	-31%	-$10.3M	0.94%	37
2014 Q3	$32.6M	Buy	248,110 +72,487	+41%	+$8.64M	0.96%	39
2014 Q2	$22.1M	Buy	175,623 +25,623	+17%	+$3.27M	0.74%	43
2014 Q1	$19.8M	Sell	150,000 -206,687	-58%	-$28.3M	0.51%	60
2013 Q4	$41.9M	Buy	356,687 +279,254	+361%	+$30.6M	1.28%	19
2013 Q3	$8.08M	Sell	77,433 -11,072	-13%	-$1.08M	0.3%	107
2013 Q2	$7.62M	Buy	+88,505	New	+$6.97M	0.32%	96

Other funds holding BHC

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Ascend Capital's BHC Position: Q1 2016 in Review

Ascend Capital sold out of Bausch Health (BHC) in Q1 2016, closing a stake of 80,000 shares — an estimated $8.13M sold.

Ascend Capital first reported a position in BHC in Q2 2013 and held it in 11 quarters. The position peaked at $41.9M in Q4 2013. 389 funds tracked by Wall St. Rank hold BHC as of Q1 2016.

Ascend Capital reported no remaining Bausch Health position as of Q1 2016 after selling out during the quarter.
Ascend Capital sold 80,000 Bausch Health shares in Q1 2016, an estimated $8.13M.
Ascend Capital first reported a position in Bausch Health in Q2 2013 and held it in 11 quarters.
Ascend Capital's Bausch Health position peaked at $41.9M in Q4 2013.
389 funds tracked by Wall St. Rank held Bausch Health as of Q1 2016.

Based on Ascend Capital's 13F filing for Q1 2016, filed 13 May 2016.